-
1
-
-
77952484017
-
Challenges for molecular magnetic resonance imaging
-
Terreno E., Castelli D.D., Viale A., Aime S. Challenges for molecular magnetic resonance imaging. Chem Rev 2010, 110:3019-3042.
-
(2010)
Chem Rev
, vol.110
, pp. 3019-3042
-
-
Terreno, E.1
Castelli, D.D.2
Viale, A.3
Aime, S.4
-
2
-
-
77952537647
-
Multimodality imaging probes: design and challenges
-
Louie A. Multimodality imaging probes: design and challenges. Chem Rev 2010, 110:3146-3195.
-
(2010)
Chem Rev
, vol.110
, pp. 3146-3195
-
-
Louie, A.1
-
3
-
-
37349014497
-
Use of contrast agents for liver MRI
-
Ward J. Use of contrast agents for liver MRI. Radiography 2007, 13:e54-72.
-
(2007)
Radiography
, vol.13
-
-
Ward, J.1
-
5
-
-
34249300810
-
MR contrast agents for liver imaging: what, when, how
-
Gandhi S.N., Brown M.A., Wong J.G., Aguirre D.A., Sirlin C.B. MR contrast agents for liver imaging: what, when, how. Radiographics 2006, 26:1621-1636.
-
(2006)
Radiographics
, vol.26
, pp. 1621-1636
-
-
Gandhi, S.N.1
Brown, M.A.2
Wong, J.G.3
Aguirre, D.A.4
Sirlin, C.B.5
-
6
-
-
84871659077
-
Gadolinium-based contrast agents for magnetic resonancecancer imaging
-
Zhou Z., Lu Z.-R. Gadolinium-based contrast agents for magnetic resonancecancer imaging. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2013, 5:1-18.
-
(2013)
Wiley Interdiscip Rev Nanomed Nanobiotechnol
, vol.5
, pp. 1-18
-
-
Zhou, Z.1
Lu, Z.-R.2
-
7
-
-
34548524200
-
Small molecular gadolinium(III) complexes as MRI contrast agents for diagnostic imaging
-
Chan K.W.-Y., Wong W.-T. Small molecular gadolinium(III) complexes as MRI contrast agents for diagnostic imaging. Coord Chem Rev 2007, 251:2428-2451.
-
(2007)
Coord Chem Rev
, vol.251
, pp. 2428-2451
-
-
Chan, K.W.-Y.1
Wong, W.-T.2
-
8
-
-
0346270559
-
Currently used non-specific extracellular MR contrast media
-
Bellin M.F., Vasile M., Morel-Precetti S. Currently used non-specific extracellular MR contrast media. Eur Radiol 2003, 13:2688-2698.
-
(2003)
Eur Radiol
, vol.13
, pp. 2688-2698
-
-
Bellin, M.F.1
Vasile, M.2
Morel-Precetti, S.3
-
9
-
-
43049114497
-
Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: a summary of the medical literature reporting
-
Broome D.R. Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: a summary of the medical literature reporting. Eur J Radiol 2008, 66:230-234.
-
(2008)
Eur J Radiol
, vol.66
, pp. 230-234
-
-
Broome, D.R.1
-
10
-
-
33847239121
-
Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis
-
Kuo P.H., Kanal E., Abu-Alfa A.K., Cowper S.E. Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis. Radiology 2007, 242:647-649.
-
(2007)
Radiology
, vol.242
, pp. 647-649
-
-
Kuo, P.H.1
Kanal, E.2
Abu-Alfa, A.K.3
Cowper, S.E.4
-
11
-
-
79958776497
-
Synthesis and bio-functionalization of magnetic nanoparticles for medical diagnosis and treatment
-
Schladt T.D., Schneider K., Schild H., Tremel W. Synthesis and bio-functionalization of magnetic nanoparticles for medical diagnosis and treatment. Dalton Trans 2011, 40:6315-6343.
-
(2011)
Dalton Trans
, vol.40
, pp. 6315-6343
-
-
Schladt, T.D.1
Schneider, K.2
Schild, H.3
Tremel, W.4
-
12
-
-
67649264901
-
Inorganic nanoparticles for MRI contrast agents
-
Na H.B., Song I.C., Hyeon T. Inorganic nanoparticles for MRI contrast agents. Adv Mater 2009, 21:2133-2148.
-
(2009)
Adv Mater
, vol.21
, pp. 2133-2148
-
-
Na, H.B.1
Song, I.C.2
Hyeon, T.3
-
13
-
-
47249140441
-
Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications
-
Laurent S., Forge D., Port M., Roch A., Robic C., Elst L.V., et al. Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev 2008, 108:2064-2110.
-
(2008)
Chem Rev
, vol.108
, pp. 2064-2110
-
-
Laurent, S.1
Forge, D.2
Port, M.3
Roch, A.4
Robic, C.5
Elst, L.V.6
-
14
-
-
33646115661
-
Application of superparamagnetic iron oxide to imaging of hepatocellular carcinoma
-
Tanimoto A., Kuribayashi S. Application of superparamagnetic iron oxide to imaging of hepatocellular carcinoma. Eur J Radiol 2006, 58:200-216.
-
(2006)
Eur J Radiol
, vol.58
, pp. 200-216
-
-
Tanimoto, A.1
Kuribayashi, S.2
-
15
-
-
33751410697
-
Recent advances in iron oxide nanocrystal technology for medical imaging
-
Corot C., Robert P., Idée J.-M., Port M. Recent advances in iron oxide nanocrystal technology for medical imaging. Adv Drug Deliv Rev 2006, 58:1471-1504.
-
(2006)
Adv Drug Deliv Rev
, vol.58
, pp. 1471-1504
-
-
Corot, C.1
Robert, P.2
Idée, J.-M.3
Port, M.4
-
16
-
-
78650743445
-
Effects of nanoparticle size on cellular uptake and liver MRI with polyvinylpyrrolidone-coated iron oxide nanoparticles
-
Huang J., Bu L., Xie J., Chen K., Cheng Z., Li X., et al. Effects of nanoparticle size on cellular uptake and liver MRI with polyvinylpyrrolidone-coated iron oxide nanoparticles. ACS Nano 2010, 4:7151-7160.
-
(2010)
ACS Nano
, vol.4
, pp. 7151-7160
-
-
Huang, J.1
Bu, L.2
Xie, J.3
Chen, K.4
Cheng, Z.5
Li, X.6
-
17
-
-
0023801420
-
Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver
-
Stark D.D., Weissleder R., Elizondo G., Hahn P.F., Saini S., Todd L.E., et al. Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver. Radiology 1988, 168:297-301.
-
(1988)
Radiology
, vol.168
, pp. 297-301
-
-
Stark, D.D.1
Weissleder, R.2
Elizondo, G.3
Hahn, P.F.4
Saini, S.5
Todd, L.E.6
-
18
-
-
0028020159
-
Liver MR imaging with iron oxides: toward consensus and clinical practice
-
Weissleder R. Liver MR imaging with iron oxides: toward consensus and clinical practice. Radiology 1994, 193:593-595.
-
(1994)
Radiology
, vol.193
, pp. 593-595
-
-
Weissleder, R.1
-
19
-
-
84859899426
-
Manganese(II) complexes as potential contrast agents for MRI
-
Drahoš B., Lukeš I., Tóth É. Manganese(II) complexes as potential contrast agents for MRI. Eur J Inorg Chem 2012, 1975-1986.
-
(2012)
Eur J Inorg Chem
, pp. 1975-1986
-
-
Drahoš, B.1
Lukeš, I.2
Tóth, É.3
-
20
-
-
84859884307
-
Manganese-enhanced MRI contrast agents: from small chelates to nanosized hybrids
-
Kueny-Stotz M., Garofalo A., Felder-Flesch D. Manganese-enhanced MRI contrast agents: from small chelates to nanosized hybrids. Eur J Inorg Chem 2012, 1987-2005.
-
(2012)
Eur J Inorg Chem
, pp. 1987-2005
-
-
Kueny-Stotz, M.1
Garofalo, A.2
Felder-Flesch, D.3
-
21
-
-
80053278341
-
Manganese-based MRI contrast agents: past, present, and future
-
Pan D., Schmieder A.H., Wickline S.A., Lanza G.M. Manganese-based MRI contrast agents: past, present, and future. Tetrahedron 2011, 67:8431-8444.
-
(2011)
Tetrahedron
, vol.67
, pp. 8431-8444
-
-
Pan, D.1
Schmieder, A.H.2
Wickline, S.A.3
Lanza, G.M.4
-
22
-
-
77449106886
-
Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree
-
Seal M.K., Catalano O.A., Saini S., Hahn P.F., Sahani D.V. Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree. Radiographics 2009, 29:1725-1748.
-
(2009)
Radiographics
, vol.29
, pp. 1725-1748
-
-
Seal, M.K.1
Catalano, O.A.2
Saini, S.3
Hahn, P.F.4
Sahani, D.V.5
-
23
-
-
0036901599
-
MnDPDP enhanced magnetic resonance imaging of focal liver lesions
-
King L.J., Burkill J.C., Scurr E.D., Vlavianos P., Murray-Lyons I., Healy J.C. MnDPDP enhanced magnetic resonance imaging of focal liver lesions. Clin Radiol 2002, 57:1047-1057.
-
(2002)
Clin Radiol
, vol.57
, pp. 1047-1057
-
-
King, L.J.1
Burkill, J.C.2
Scurr, E.D.3
Vlavianos, P.4
Murray-Lyons, I.5
Healy, J.C.6
-
24
-
-
0025961781
-
Hepatobiliary MR imaging: first human experience with MnDPDP
-
Lim K.O., Stark D.D., Leese P.T., Pfefferbaum A., Rocklage S.M., Quay S.C. Hepatobiliary MR imaging: first human experience with MnDPDP. Radiology 1991, 178:79-82.
-
(1991)
Radiology
, vol.178
, pp. 79-82
-
-
Lim, K.O.1
Stark, D.D.2
Leese, P.T.3
Pfefferbaum, A.4
Rocklage, S.M.5
Quay, S.C.6
-
25
-
-
0031182136
-
Metabolism and pharmacokinetics of MnDPDP in man
-
Toft K.G., Hustvedt S.O., Grant D., Martinsen I., Gordon P.B., Friisk G.A., et al. Metabolism and pharmacokinetics of MnDPDP in man. Acta Radiol 1997, 38:677-689.
-
(1997)
Acta Radiol
, vol.38
, pp. 677-689
-
-
Toft, K.G.1
Hustvedt, S.O.2
Grant, D.3
Martinsen, I.4
Gordon, P.B.5
Friisk, G.A.6
-
26
-
-
82855179425
-
Manganese based MR contrast agents: formulation and clinical applications
-
Chabanova E., Logager V.B., Moller J.M., Thomsen H.S. Manganese based MR contrast agents: formulation and clinical applications. Open Drug Saf J 2011, 2:29-38.
-
(2011)
Open Drug Saf J
, vol.2
, pp. 29-38
-
-
Chabanova, E.1
Logager, V.B.2
Moller, J.M.3
Thomsen, H.S.4
-
27
-
-
23344440638
-
Safety of MR liver specific contrast media
-
Bellin M.F., Webb J.A., van der Molen A.J., Thomsen H.S., Morcos S.K. Safety of MR liver specific contrast media. Eur Radiol 2005, 15:1607-1614.
-
(2005)
Eur Radiol
, vol.15
, pp. 1607-1614
-
-
Bellin, M.F.1
Webb, J.A.2
van der Molen, A.J.3
Thomsen, H.S.4
Morcos, S.K.5
-
28
-
-
77949419135
-
Does vitreous silica contradict the toxicity of the crystalline silica paradigm?
-
Ghiazza M., Polimeni M., Fenoglio I., Gazzano E., Ghigo D., Fubini B. Does vitreous silica contradict the toxicity of the crystalline silica paradigm?. Chem Res Toxicol 2010, 23:620-629.
-
(2010)
Chem Res Toxicol
, vol.23
, pp. 620-629
-
-
Ghiazza, M.1
Polimeni, M.2
Fenoglio, I.3
Gazzano, E.4
Ghigo, D.5
Fubini, B.6
-
29
-
-
33746211280
-
Invitro cytotoxicity of oxide nanoparticles: comparison to asbestos, silica, and the effect of particle solubility
-
Brunner T.J., Wick P., Manser P., Spohn P., Grass R.N., Limbach L.K., et al. Invitro cytotoxicity of oxide nanoparticles: comparison to asbestos, silica, and the effect of particle solubility. Environ Sci Technol 2006, 40:4374-4381.
-
(2006)
Environ Sci Technol
, vol.40
, pp. 4374-4381
-
-
Brunner, T.J.1
Wick, P.2
Manser, P.3
Spohn, P.4
Grass, R.N.5
Limbach, L.K.6
-
30
-
-
84864290990
-
Manganese oxide-based multifunctionalized mesoporous silica nanoparticles for pH-responsive MRI, ultrasonography and circumvention of MDR in cancer cells
-
Chen Y., Yin Q., Ji X., Zhang S., Chen H., Zheng Y., et al. Manganese oxide-based multifunctionalized mesoporous silica nanoparticles for pH-responsive MRI, ultrasonography and circumvention of MDR in cancer cells. Biomaterials 2012, 33:7126-7137.
-
(2012)
Biomaterials
, vol.33
, pp. 7126-7137
-
-
Chen, Y.1
Yin, Q.2
Ji, X.3
Zhang, S.4
Chen, H.5
Zheng, Y.6
-
32
-
-
58249114007
-
Hollow manganese oxide nanoparticles as multifunctional agents for magnetic resonance imaging and drug delivery
-
Shin J., Anisur R.M., Ko M.K., Im G.H., Lee J.H., Lee I.S. Hollow manganese oxide nanoparticles as multifunctional agents for magnetic resonance imaging and drug delivery. Angew Chem Int Ed 2009, 48:321-324.
-
(2009)
Angew Chem Int Ed
, vol.48
, pp. 321-324
-
-
Shin, J.1
Anisur, R.M.2
Ko, M.K.3
Im, G.H.4
Lee, J.H.5
Lee, I.S.6
-
33
-
-
55549086881
-
Manganese-based nanoscale metal-organic frameworks for magnetic resonance imaging
-
Taylor K.M.L., Rieter W.J., Lin W. Manganese-based nanoscale metal-organic frameworks for magnetic resonance imaging. JAm Chem Soc 2008, 130:14358-14359.
-
(2008)
JAm Chem Soc
, vol.130
, pp. 14358-14359
-
-
Taylor, K.M.L.1
Rieter, W.J.2
Lin, W.3
-
34
-
-
49049096312
-
Convertible manganese contrast for molecular and cellular MRI
-
Shapiro E.M., Koretsky A.P. Convertible manganese contrast for molecular and cellular MRI. Magn Reson Med 2008, 60:265-269.
-
(2008)
Magn Reson Med
, vol.60
, pp. 265-269
-
-
Shapiro, E.M.1
Koretsky, A.P.2
-
36
-
-
80051496142
-
Biocompatible and pH-sensitive PLGA encapsulated MnO nanocrystals for molecular and cellular MRI
-
Bennewitz M.F., Lobo T.L., Nkansah M.K., Ulas G., Brudvig G.W., Shapiro E.M. Biocompatible and pH-sensitive PLGA encapsulated MnO nanocrystals for molecular and cellular MRI. ACS Nano 2011, 5:3438-3446.
-
(2011)
ACS Nano
, vol.5
, pp. 3438-3446
-
-
Bennewitz, M.F.1
Lobo, T.L.2
Nkansah, M.K.3
Ulas, G.4
Brudvig, G.W.5
Shapiro, E.M.6
-
37
-
-
17144386929
-
Silica-coated nanocomposites of magnetic nanoparticles and quantum dots
-
Yi D.K., Selvan S.T., Lee S.S., Papaefthymiou G.C., Kundaliya D., Ying J.Y. Silica-coated nanocomposites of magnetic nanoparticles and quantum dots. JAm Chem Soc 2005, 127:4990-4991.
-
(2005)
JAm Chem Soc
, vol.127
, pp. 4990-4991
-
-
Yi, D.K.1
Selvan, S.T.2
Lee, S.S.3
Papaefthymiou, G.C.4
Kundaliya, D.5
Ying, J.Y.6
-
39
-
-
77952722303
-
Hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging-correlation with expression of sinusoidal and canalicular transporters and bile accumulation
-
Tsuboyama T., Onishi H., Kim T., Akita H., Hori M., Tatsumi M., et al. Hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging-correlation with expression of sinusoidal and canalicular transporters and bile accumulation. Radiology 2010, 255:824-833.
-
(2010)
Radiology
, vol.255
, pp. 824-833
-
-
Tsuboyama, T.1
Onishi, H.2
Kim, T.3
Akita, H.4
Hori, M.5
Tatsumi, M.6
-
40
-
-
84866729700
-
Invivo biodistribution and pharmacokinetics of silica nanoparticles as a function of geometry, porosity and surface characteristics
-
Yu T., Hubbard D., Ray A., Ghandehari H. Invivo biodistribution and pharmacokinetics of silica nanoparticles as a function of geometry, porosity and surface characteristics. JControl Release 2012, 163:46-54.
-
(2012)
JControl Release
, vol.163
, pp. 46-54
-
-
Yu, T.1
Hubbard, D.2
Ray, A.3
Ghandehari, H.4
-
41
-
-
78651342869
-
Invivo biodistribution and urinary excretion of mesoporous silica nanoparticles: effects of particle size and PEGylation
-
He Q., Zhang Z., Gao F., Li Y., Shi J. Invivo biodistribution and urinary excretion of mesoporous silica nanoparticles: effects of particle size and PEGylation. Small 2011, 7:271-280.
-
(2011)
Small
, vol.7
, pp. 271-280
-
-
He, Q.1
Zhang, Z.2
Gao, F.3
Li, Y.4
Shi, J.5
-
42
-
-
79961071789
-
The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility invivo
-
Huang X., Li L., Liu T., Hao N., Liu H., Chen D., et al. The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility invivo. ACS Nano 2011, 5:5390-5399.
-
(2011)
ACS Nano
, vol.5
, pp. 5390-5399
-
-
Huang, X.1
Li, L.2
Liu, T.3
Hao, N.4
Liu, H.5
Chen, D.6
|